RFA induces tumor cell death by denaturing proteins within local tissue, while also enhancing immune cell infiltration into the TME, thereby exerting a tumoricidal effect.[41] This study presents a novel nano‐strategy designed to enhance the therapeutic efficacy of RFA in HCC by targeting FABP5, a critical molecule implicated in HCC progression. Here, FABP5 is linked to neoplasm.